Be sure to join our cohort of Center faculty in attendance at the American Thoracic Society Conference this year! Registration is open through May 12, late registration available onsite.

World Lung Health Award

UCSF's Laurence Huang, MD will be honored on Saturday, May 14, 4:30pm in the Moscone Center, Hall E with the World Lung Health Award at ATS.

The World Lung Health Award recognizes contributions to improving world lung health in the area of translational or implementation research, delivery of health care, continuing education or care of patients with lung disease, or related political advocacy with a special emphasis on efforts that have the potential to eliminate gender, racial, ethnic, or economic health disparities worldwide.

Tuberculosis-Related Events and Talks at ATS

Make sure you don't miss all the TB-related events, talks, posters, and awards during the ATS conference at the Moscone Center. 

Highlighted talks include a scientific symposium featuring Drs. Christina Yoon and Adithya Cattamanchi on Sunday, May 15. 

Find more information on TB-related events with our schedule for ATS linked on the Center website (below). 

Progress in TB Vaccine Development

Talk by Ann Ginsberg, MD, PhD

Deputy Director, TB Vaccines, Bill & Melinda Gates Foundation

Ann M. Ginsberg, M.D., Ph.D., is Deputy Director, TB Vaccines in the Global Health Division of the Bill & Melinda Gates Foundation. Dr. Ginsberg has conducted and led TB research and product development programs for 25 years, including 15 years leading and designing clinical strategy for development of TB vaccines and drug regimens of high priority for the developing world. She previously served as the Chief, Respiratory Diseases Branch, NIAID, NIH, as Director, Project Management at Merck Research Laboratories, as Chief Medical Officer at the Global Alliance for TB Drug Development, as Chief Medical Officer at Aeras and as Senior Technical Advisor at IAVI. In these roles, she oversaw in addition to numerous early stage drug and vaccine candidates, the early clinical development program of Pretomanid® and two recent, groundbreaking TB vaccine efficacy trials - of BCG revaccination and M72/AS01E. Dr. Ginsberg has served on numerous national and international advisory committees on vaccines and global health, including the U.S. National Vaccine Advisory Committee. Her undergraduate degree is from Harvard University, her Ph.D. in Molecular Biology from Washington University and her M.D. from Columbia University. She was Board-certified in Anatomic Pathology.

Understanding Risk of Progression to TB Disease

Talk by Sara Suliman, PhD, MPH

Assistant Professor, Division of Experimental Medicine, UCSF

Dr. Sara Suliman is an immunologist by training with a focus on understanding risk of progression to active TB disease and developing predictive biomarkers. She was an instructor at the Brigham and Women's Hospital and Harvard Medical Schools, where she focused on dissecting host factors associated with TB risk, including genetic associations and non-classical T cell responses to mycobacterial antigens. She also led the Mass General/Brigham COVID diagnostics accelerator lab. She is currently an assistant professor at the division of experimental medicine at UCSF and the Zuckerberg San Francisco General Hospital, where her lab focuses on identifying host mechanisms associated with TB progression. 

The Center for Tuberculosis at UCSF wants to capture every success, funded project, and publication by its faculty. If you have news to share, please fill out this survey to keep our website updated.

Please contact the Center's manager, Sarah K. Hutch, for any CTB-related needs or questions.